- Home
- GOSS vs GROY Comparison
GOSS vs GROY Comparison
Compare GOSS & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- GROY
- Stock Information
- Founded
- GOSS 2015
- GROY 2020
- Country
- GOSS United States
- GROY Canada
- Employees
- GOSS N/A
- GROY N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- GROY
- Sector
- GOSS Health Care
- GROY
- Exchange
- GOSS Nasdaq
- GROY Nasdaq
- Market Cap
- GOSS 586.6M
- GROY 618.0M
- IPO Year
- GOSS 2019
- GROY 2021
- Fundamental
- Price
- GOSS $2.94
- GROY $3.86
- Analyst Decision
- GOSS Strong Buy
- GROY Strong Buy
- Analyst Count
- GOSS 4
- GROY 4
- Target Price
- GOSS $8.50
- GROY $4.58
- AVG Volume (30 Days)
- GOSS 3.3M
- GROY 2.6M
- Earning Date
- GOSS 11-06-2025
- GROY 11-03-2025
- Dividend Yield
- GOSS N/A
- GROY N/A
- EPS Growth
- GOSS N/A
- GROY N/A
- EPS
- GOSS N/A
- GROY N/A
- Revenue
- GOSS $40,237,000.00
- GROY $12,376,000.00
- Revenue This Year
- GOSS N/A
- GROY $82.74
- Revenue Next Year
- GOSS $30.65
- GROY $51.73
- P/E Ratio
- GOSS N/A
- GROY N/A
- Revenue Growth
- GOSS N/A
- GROY 90.37
- 52 Week Low
- GOSS $0.66
- GROY $1.16
- 52 Week High
- GOSS $2.98
- GROY $3.99
- Technical
- Relative Strength Index (RSI)
- GOSS 76.74
- GROY 71.60
- Support Level
- GOSS $2.41
- GROY $3.47
- Resistance Level
- GOSS $2.71
- GROY $3.99
- Average True Range (ATR)
- GOSS 0.19
- GROY 0.18
- MACD
- GOSS 0.04
- GROY 0.04
- Stochastic Oscillator
- GOSS 96.37
- GROY 87.73
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.